AIRSUPRA 90 ug/1

AIRSUPRA 90 ug/1 combines albuterol sulfate and budesonide for respiratory conditions. This metered aerosol inhaler offers dual-action relief for asthma and COPD management.

AIRSUPRA 90 ug/1 is primarily used for the maintenance and prevention of asthma and chronic obstructive pulmonary disease (COPD). The combination of albuterol sulfate and budesonide works to open airways and reduce inflammation. This inhaler is often prescribed for long-term management of respiratory conditions where both bronchodilation and anti-inflammatory effects are beneficial.

Common effects of AIRSUPRA 90 ug/1 may include improved breathing and reduced wheezing due to its bronchodilator and anti-inflammatory properties. Some users may experience mild side effects such as throat irritation or a slight increase in heart rate.

AIRSUPRA 90 ug/1 should be used as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. Patients should be aware of potential side effects and consult their healthcare provider if they experience any adverse reactions.

AIRSUPRA 90 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this inhaler.